News & Perspective

Oct 19, 2018

Oct 19, 2018

ASP Scan (Weekly) for Oct 19, 2018

Undetected MDR-TB in South Africa
Carbapenem prescribing algorithm
Rapid susceptibility tests
AMR surveillance in South Korea
Biomarkers and sepsis management
C difficile on hospital bed sheets
Colistin resistance diagnostics
Dearth of point-of-care tests
New-antibiotic distribution

Jul 13, 2018

Jul 13, 2018

ASP Scan (Weekly) for Jul 13, 2018

Stewardship nudge
MDR-TB in kids
Mycoplasma genitalium guidelines
Fluoroquinolone safety update
Kids' fever and antibiotics
Resistant Klebsiella in Europe
Ceftolozane-tazobactam against E coli
UK competition for AMR innovation
Funding for new gonorrhea drug
Antibiotic course for pneumonia
CRE reduction in Israel
Southeast Asian neonatal infections

Mar 01, 2018

Mar 01, 2018

News Scan for Mar 01, 2018

Low flu VE in Europe
Novavax flu vaccine trial
Avian flu outbreaks
Public health spending report card
Biodefense caucus forms

Sep 08, 2017

Sep 08, 2017

ASP Scan (Weekly) for Sep 08, 2017

ESBL-E in pregnant women
Antimicrobial resistance in Southeast Asia
Precision antimicrobials
Money for antibiotic development
Canada AMR framework
Pharmacist stewardship
CRE treatment

Feb 24, 2017

Feb 24, 2017

ASP Scan (Weekly) for Feb 24, 2017

New diagnostic tests
Antibiotic prescribing frequency
Possible Candida auris drug
MRSA pattern shifts
Resistant malaria in Africa
Antibacterial skin lotion
MDR Enterobacteriaceae in children
MCR-1 in Chinese pets
MDR-TB testing, treatment
Neonatal sepsis risk calculator
Antibiotic-free chicken
Klebsiella pneumoniae in UK, Ireland
Antibiotic resistance in Indian kids

Mar 23, 2012

Mar 23, 2012

Experts seek greater push to stop drug-resistant TB

(CIDRAP News) – Tuberculosis (TB) experts who met in Geneva this week said the global TB community needs to step up the fight against drug resistance and increase appropriate care and treatment "to avoid a scenario where TB becomes incurable," the World Health Organization (WHO) said today.

May 18, 2011

May 18, 2011

Experts: Regulatory issues are main reason for keeping smallpox virus

(CIDRAP News) – When the World Health Assembly (WHA) considers the fate of the remaining stocks of smallpox virus this week, the debate is likely to be framed in part by a report from a group of independent experts that says the only strong reason for keeping the virus is to satisfy strict regulatory requirements for new vaccines and antivirals.

Newsletter Sign-up

Get CIDRAP news and other free newsletters.

Sign up now»

OUR UNDERWRITERS

Unrestricted financial support provided by

Bentson Foundation 3MAccelerate DiagnosticsGilead 
Grant support for ASP provided by


bioMérieux

  Become an underwriter»